TAYLOR HOWELL: Open Payments
NPI 1609641091 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,026 in 56 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $1,023 · 2025 $1,026
Food & beverage: $1,026
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $387 |
| Madrigal Pharmaceuticals | 4 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $113 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Intercept Pharmaceuticals, Inc. | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Janssen Biotech, Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Amgen Inc. | 2 | $30 |
Products named: RINVOQ, REZDIFFRA, SKYRIZI, DUPIXENT, CREON, ENTYVIO, OCALIVA, GATTEX.
Industry payments across FL — which companies pay providers there.
